Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New modular shoulder implant aims to improve outcomes in tough revision surgeries

NCT ID NCT03270982

Disease control Sponsor: Zimmer Biomet Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new modular shoulder replacement system in 105 people who need complex revision surgery due to joint disease, trauma, or cancer. The device can replace part or all of the upper arm bone. Researchers are tracking how long the implant lasts and how well patients can use their arm afterward.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Comprehensive Segmental Revision System (a modular shoulder replacement device)
What this could lead to
If successful, this device could provide a more durable and functional option for people needing complex shoulder revision surgery.
What could go wrong
This is an early-stage study with only 105 participants, so results may not apply to everyone. Device failure or complications like infection are possible risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 105 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2016

Expected to finish

Dec 2035

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study population will come from Primary Care Clinics

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Non Inflammatory Degenerative joint disease, including osteoarthritis, and avascular necrosis * Rheumatoid arthritis * Revision where other devices or treatments have failed * Correction of functional deformity * Oncology applications including bone loss due to tumour resection Exclusion Criteria: * Sepsis ( active) * Infection ( active) * Osteomyelitis (active)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Avascular necrosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

avascular necrosis injury neoplasm neurodegenerative disease osteoarthritis rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Degenerative disease Oncology Revision surgery Rheumatoid arthritis Trauma

Contacts and locations

Locations

  • Department of Orthopedic Surgery, Rigshospitalet University of Copenhagen

    Copenhagen, Denmark

  • Nova Scotia Health Authority

    Halifax, Nova Scotia, B3H-1796, Canada

  • Royal Gwent Hospital

    Newport, Wales, NP20 2UB, United Kingdom

  • Royal Liverpool University Hospital

    Liverpool, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.